Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_assertion type Assertion NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_head.
- NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_assertion wasGeneratedBy ECO_0000203 NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_provenance.
- NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_assertion wasDerivedFrom befree-2016 NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_provenance.
- NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_assertion SIO_000772 17635819 NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_provenance.
- NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_assertion evidence source_evidence_literature NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_provenance.
- NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_assertion description "[Pathologically, high circulating levels of FGF23 result in hypophosphatemia, decreased production of 1,25(OH)(2)D, elevated parathyroid hormone and rickets/osteomalacia in patients with functioning kidneys, whereas low levels are associated with tumoral calcinosis, hyperphosphatemia and elevated 1,25(OH)(2)D. In addition, patients with chronic kidney disease (CKD) exhibit marked elevations of circulating FGF23.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP620400.RAU7xyURlu1YDW2YGagG4_boTSyJ6i4z9tL517oQACtNA130_provenance.